May 20, 2024
Image default
Business Culture

Pfizer says its COVID-19 vaccine is over 90 percent effective

Pfizer has been working with BioNTech on a vaccine for COVID-19, and their early analysis suggests their vaccine candidate is over 90% effective. That would be a much higher than expected rate of efficacy from one of the earliest vaccine candidates for the virus. The U.S. Food and Drug Administration is looking for at least 50% efficacy from a COVID-19 vaccine.Q3 2020 hedge fund letters, conferences and morePfizer vaccine may be very effectiveThe interim analysis focused on the first 94 confirmed cases of COVID-19 among the over 43,000 volunteers who received either two doses of the vaccine or…

Read More

Related posts

UK suffers record recession on virus fallout

The_Proponent

Bitcoin, ether hit all-time highs as momentum accelerates

The_Proponent

Amazon workers in New York begin voting in union election

The_Proponent

Here’s How to Prepare For ‘The Last Jedi’

The_Proponent

David Bowie’s son remembers music icon on anniversary of his death

The_Proponent

U.S. oil dips below $100 a barrel on economic worries, strong dollar

The_Proponent

Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.